Loading organizations...

§ Venture Capital · 300 Park Avenue, 25th Floor, New York, NY 10022
Healthcare-focused hedge fund manager that invested in medical technology, pharmaceutical, and biotechnology companies.
Broadfin Capital operates as an investment management firm primarily concentrating on unique opportunities within the healthcare sector. The entity employs a flexible investment approach, engaging across various asset classes while maintaining a strong emphasis on healthcare. Its operational scope includes a broad range of investment activities, reflecting a strategic allocation of capital.
Kevin Kotler established Broadfin Capital, LLC in June 2005, serving as its Founder and Portfolio Manager. The firm’s foundational insight revolved around applying a fundamental research-based, value-oriented investment strategy specifically to the healthcare industry. This specialized focus allowed the firm to navigate and capitalize on the complexities inherent in the sector.
The firm historically served accredited and qualified investors through its healthcare funds. Following an evolution in its structure, Broadfin Holdings, launched in 2020, now operates as a family office, continuing the dedication to strategic capital deployment. Its vision remains centered on identifying and nurturing long-term value in the healthcare ecosystem and beyond.
Broadfin Advisors has 1 tracked investment across 1 company. The latest tracked deal is $16.0M Series A in Luminopia in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2023 | Luminopia | $16.0M Series A | U.S. Venture Partners | Alumni Ventures, Amzak Health Investors, Deerfield Management, OrbiMed, ShangBay Capital, The Vertical Group |